ArticleScientific reports2013

Silibinin suppresses EMT-driven erlotinib resistance by reversing the high miR-21/low miR-200c signature in vivo.

Sílvia Cufí et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.